Literature DB >> 19871691

PREPARATION OF DRIED HEMOGLOBIN WITHOUT LOSS OF ACTIVITY.

L E Farr1, A Hiller, D D Van Slyke.   

Abstract

The technique for freezing, drying, and preserving in vacuo which is in common use for plasma can be successfully applied to hemoglobin solutions when the hemoglobin is first deoxygenated to the extent of 99.7 per cent or more. In confirmation of Morrison and Hisey, the preliminary deoxygenation of the solution is found necessary to avoid formation of methemoglobin during drying. If a solution of oxyhemoglobin is frozen and dried, 20 to 30 per cent is changed to methemoglobin. Deoxygnated hemoglobin dried and preserved in vacuo retained all its oxygenbinding activity for 180 days, when stored at temperatures from 4 degrees to 30 degrees C. Storage at 38 degrees C. for 92 days, or at 56 degrees for 7 days, caused no loss in activity. The dried hemoglobin had a foam structure which caused it to dissolve immediately upon contact with water. Deoxygnated hemoglobin in the dry state was partly converted to methemoglobin by even momentary contact with oxygen. When, however, the deoxygnated hemoglobin was dissolved before it was exposed to air, the hemoglobin in solution was relatively stable, and could be stored for months at 4 degrees in contact with air without significant loss of activity.

Entities:  

Keywords:  HEMOGLOBIN/dried

Mesh:

Substances:

Year:  1947        PMID: 19871691      PMCID: PMC2135752          DOI: 10.1084/jem.86.6.465

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  PREPARATION OF HEMOGLOBIN SOLUTIONS FOR INTRAVENOUS INFUSION.

Authors:  P B Hamilton; L E Farr; A Hiller; D D Van Slyke
Journal:  J Exp Med       Date:  1947-11-30       Impact factor: 14.307

  1 in total
  2 in total

1.  PREPARATION OF HEMOGLOBIN SOLUTIONS FOR INTRAVENOUS INFUSION.

Authors:  P B Hamilton; L E Farr; A Hiller; D D Van Slyke
Journal:  J Exp Med       Date:  1947-11-30       Impact factor: 14.307

2.  Evaluation of a stroma-free hemoglobin solution for use as a plasma expander.

Authors:  S F Rabiner; J R Helbert; H Lopas; L H Friedman
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.